Lotensin Hct
NDC 54868-5313
Product Information
Lotensin Hct is a NDA-approved product labeled by Physicians Total Care, Inc.. This medication is a combination of two drugs, an ACE inhibitor (benazepril) and a "water pill"/diuretic (hydrochlorothiazide). It is supplied as a gray product. This product entry covers the primary NDC 54868-5313 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
RED (C48326)
Code Structure Chart
Product Details
What is NDC 54868-5313?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BENAZEPRIL HYDROCHLORIDE (UNII: N1SN99T69T)
- BENAZEPRILAT (UNII: JRM708L703) (Active Moiety)
- HYDROCHLOROTHIAZIDE (UNII: 0J48LPH2TH)
- HYDROCHLOROTHIAZIDE (UNII: 0J48LPH2TH) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- CROSPOVIDONE (UNII: 68401960MK)
- HYDROGENATED CASTOR OIL (UNII: ZF94AP8MEY)
- LACTOSE (UNII: J2B2A4N98G)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 898367 - benazepril HCl 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet
- RxCUI: 898367 - benazepril hydrochloride 20 MG / hydrochlorothiazide 12.5 MG Oral Tablet
- RxCUI: 898367 - benazepril hydrochloride 20 MG / HCTZ 12.5 MG Oral Tablet
- RxCUI: 898367 - BZP hydrochloride 20 MG / HCTZ 12.5 MG Oral Tablet
- RxCUI: 898371 - Lotensin HCT 20 MG / 12.5 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.